Tumolo Annette's Form 4 filing
Bio-Rad Laboratories, Inc. (BIO) · filed Nov 15, 2021
- Accession no.
- 0001062993-21-010826
- Filed
- Nov 15, 2021
- Trade date
- Nov 11-12, 2021
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 10 non-derivative transactions and 5 derivative transactions. Open-market sales total $4.76M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Tumolo AnnetteCIK 0001717996 | Officer (Executive Vice President) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 11, 2021 | Bio-Rad A Common Stock | MOption exerciseAcquired | +613 | $333.34 | +$204,337.42 | 5,206.35 | Direct | |
| Nov 11, 2021 | Bio-Rad A Common Stock | MOption exerciseAcquired | +500 | $333.34 | +$166,670 | 5,706.35 | Direct | |
| Nov 11, 2021 | Bio-Rad A Common Stock | MOption exerciseAcquired | +433 | $524.30 | +$227,021.9 | 6,139.35 | Direct | |
| Nov 11, 2021 | Bio-Rad A Common Stock | SSaleDisposed | −433 | $748.08 | −$323,918.64 | 5,706.35 | Direct | |
| Nov 11, 2021 | Bio-Rad A Common Stock | SSaleDisposed | −613 | $748.84 | −$459,038.92 | 5,093.35 | Direct | |
| Nov 11, 2021 | Bio-Rad A Common Stock | SSaleDisposed | −500 | $750.00 | −$375,000 | 4,593.35 | Direct | |
| Nov 12, 2021 | Bio-Rad A Common Stock | MOption exerciseAcquired | +600 | $159.32 | +$95,592 | 5,193.35 | Direct | |
| Nov 12, 2021 | Bio-Rad A Common Stock | MOption exerciseAcquired | +2,400 | $215.98 | +$518,352 | 7,593.35 | Direct | |
| Nov 12, 2021 | Bio-Rad A Common Stock | MOption exerciseAcquired | +1,800 | $326.15 | +$587,070 | 9,393.35 | Direct | |
| Nov 12, 2021 | Bio-Rad A Common Stock | SSaleDisposed | −4,800 | $750.05 | −$3,600,240 | 4,593.35 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 11, 2021 | Bio-Rad A Common Stock | MOption exerciseDisposed | −433 | $0.00 | $0 | 1,300 | Direct | |
| Nov 11, 2021 | Bio-Rad A Common Stock | MOption exerciseDisposed | −1,113 | $0.00 | $0 | 1,671 | Direct | |
| Nov 12, 2021 | Bio-Rad A Common Stock | MOption exerciseDisposed | −1,800 | $0.00 | $0 | 1,200 | Direct | |
| Nov 12, 2021 | Bio-Rad A Common Stock | MOption exerciseDisposed | −2,400 | $0.00 | $0 | 600 | Direct | |
| Nov 12, 2021 | Bio-Rad A Common Stock | MOption exerciseDisposed | −600 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.